Primordial Genetics is proud to announce the issuance of two new patents by the United States Patent and Trademark Office. US patents 10,077,441 and 10,093,922 protect our unique genetic technology for creating microbes with improved production economics or enhanced tolerance of abiotic stress and toxic products.

Primordial Genetics has successfully applied its Function Generator technology to develop a variety of valuable traits in microbes, including increased stress & product tolerance, improved protein expression or solubility, ability to produce recalcitrant proteins, increased production rates, titers and yields of valuable primary or secondary metabolites, and enzymes with resistance to inhibitors, expanded substrate specificity or higher catalytic activity.

The two new patents significantly add to the company’s technology protections and greatly enhance our intellectual property position.